COMBIPHAR
Lulu Kumala Dewi S.T. M.M is a seasoned professional in business development and brand marketing, currently serving as GM Business Development at COMBIPHAR since January 2024. Previously, Lulu held the position of Senior Brand Marketing Manager at ENESIS GROUP from October 2021 to October 2023, where responsibilities included planning and tracking sales and marketing strategies. During a six-year tenure at PT Kino Indonesia Tbk, Lulu progressed from Product Innovation Manager to Head of Division Product Innovation, focusing on product development and innovative marketing campaigns across various categories. Earlier career experience involved roles at Godrej Consumer Products Limited, where Lulu excelled as Brand Manager, and with Wilmar Group in multiple capacities from Sales Executive to Assistant Brand Manager. Lulu holds a Master's degree in Management from Kwik Kian Gie School of Business and a Bachelor's degree in Chemical Engineering from Universitas Sriwijaya.
This person is not in any teams
This person is not in any offices
COMBIPHAR
1 followers
Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.